These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3604253)

  • 1. The bioavailability of phenylbutazone in the horse.
    Smith PB; Caldwell J; Smith RL; Horner MW; Moss MS
    Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of cefazolin in horses.
    Sams RA; Ruoff WW
    Am J Vet Res; 1985 Feb; 46(2):348-52. PubMed ID: 3994100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylbutazone in the horse: a review.
    Tobin T; Chay S; Kamerling S; Woods WE; Weckman TJ; Blake JW; Lees P
    J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of phenylbutazone preparations in the horse.
    Rose RJ; Kohnke JR; Baggot JD
    Equine Vet J; 1982 Jul; 14(3):234-7. PubMed ID: 7106088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horses.
    Greene EW; Woods WE; Tobin T
    Am J Vet Res; 1983 Jan; 44(1):57-63. PubMed ID: 6824226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations.
    Burrows GE; MacAllister CG; Beckstrom DA; Nick JT
    Am J Vet Res; 1985 Feb; 46(2):442-6. PubMed ID: 3994110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse.
    Du J; White N; Eddington ND
    Biopharm Drug Dispos; 2004 Apr; 25(3):109-16. PubMed ID: 15083499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls.
    Williams RJ; Smith JA; Boudinot FD; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):367-70. PubMed ID: 2316911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazole.
    Conte L; Ramis J; Mis R; Vilageliu J; Basi N; Forn J
    Arzneimittelforschung; 1992 Jun; 42(6):854-8. PubMed ID: 1418045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
    Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M
    Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD; Draffan GH; Dunsire JP; Zimmer A
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of [14C]avitriptan in rats and humans.
    Marathe PH; Greene DS; Barbhaiya RH
    Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.